SI3096779T1 - Sestavki in postopki za zdravljenje intracerebralne krvavitve - Google Patents

Sestavki in postopki za zdravljenje intracerebralne krvavitve

Info

Publication number
SI3096779T1
SI3096779T1 SI201531081T SI201531081T SI3096779T1 SI 3096779 T1 SI3096779 T1 SI 3096779T1 SI 201531081 T SI201531081 T SI 201531081T SI 201531081 T SI201531081 T SI 201531081T SI 3096779 T1 SI3096779 T1 SI 3096779T1
Authority
SI
Slovenia
Prior art keywords
compositions
methods
intracerebral hemorrhage
treating intracerebral
treating
Prior art date
Application number
SI201531081T
Other languages
English (en)
Slovenian (sl)
Inventor
Steven Arkin
Joachim Fruebis
Marcus E. Carr
Sunita Hett
Reema Jasuja
Debra D. Pittman
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of SI3096779T1 publication Critical patent/SI3096779T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI201531081T 2014-01-24 2015-01-15 Sestavki in postopki za zdravljenje intracerebralne krvavitve SI3096779T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461931071P 2014-01-24 2014-01-24
PCT/IB2015/050313 WO2015110939A1 (en) 2014-01-24 2015-01-15 Compositions and methods for treating intracerebral hemorrhage
EP15708578.8A EP3096779B1 (en) 2014-01-24 2015-01-15 Compositions and methods for treating intracerebral hemorrhage

Publications (1)

Publication Number Publication Date
SI3096779T1 true SI3096779T1 (sl) 2020-03-31

Family

ID=52630418

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201531081T SI3096779T1 (sl) 2014-01-24 2015-01-15 Sestavki in postopki za zdravljenje intracerebralne krvavitve

Country Status (18)

Country Link
US (2) US20160375109A1 (https=)
EP (1) EP3096779B1 (https=)
JP (1) JP6624787B2 (https=)
KR (3) KR20210008177A (https=)
CN (2) CN112156176A (https=)
AU (1) AU2015208819B2 (https=)
BR (1) BR112016014617A2 (https=)
CA (1) CA2937418A1 (https=)
DK (1) DK3096779T3 (https=)
ES (1) ES2772802T3 (https=)
HU (1) HUE047588T4 (https=)
IL (1) IL246637A0 (https=)
MX (1) MX375355B (https=)
PL (1) PL3096779T3 (https=)
PT (1) PT3096779T (https=)
RU (1) RU2016126423A (https=)
SI (1) SI3096779T1 (https=)
WO (1) WO2015110939A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2950813B1 (en) 2013-01-31 2019-09-04 Pfizer Inc Compositions and methods for counteracting factor xa inhibition
MY173548A (en) 2013-09-24 2020-02-04 Pfizer Fxa variant compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005016406D1 (de) * 2004-06-21 2009-10-15 Novo Nordisk Healthcare Ag Faktor viia oder faktor viia äquivaltenen zur prävention oder abschwächung des wachstums von hämorrhagien und/oder der ödemerzeugung nach intrazerebraler hämorrhagie (ich)
MX336958B (es) * 2005-11-15 2016-02-05 Philadelphia Children Hospital Metodos y composiciones para modular la hemostasia.
JP2011509978A (ja) * 2008-01-18 2011-03-31 ノボ ノルディスク ヘルス ケア アーゲー 選択されたＩＣＨ患者亜集団における脳内出血（ＩＣＨ）後の出血拡大、及び／又は浮腫生成の予防又は減弱のための、第ＶＩＩａ因子又は第ＶＩＩａ因子等価物の使用
PT2453910T (pt) * 2009-07-15 2016-12-07 Portola Pharm Inc Formulação de dose unitária de antídoto contra inibidores de fator xa para uso na prevenção de sangramento
KR20120061898A (ko) * 2009-08-20 2012-06-13 체에스엘 베링 게엠베하 출혈성 장애의 치료요법 및 예방 치료에 있어서의 비정맥내 투여를 위한 알부민 융합 응고 인자
JP6514893B2 (ja) * 2011-09-30 2019-05-15 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアＴｈｅ Ｃｈｉｌｄｒｅｎ’Ｓ Ｈｏｓｐｉｔａｌ Ｏｆ Ｐｈｉｌａｄｅｌｐｈｉａ 止血を調節するための組成物および方法
MX365612B (es) * 2012-07-25 2019-06-07 Catalyst Biosciences Inc Polipeptidos de factor x modificados y usos de los mismos.
EP2950813B1 (en) * 2013-01-31 2019-09-04 Pfizer Inc Compositions and methods for counteracting factor xa inhibition

Also Published As

Publication number Publication date
EP3096779B1 (en) 2019-12-18
EP3096779A1 (en) 2016-11-30
PT3096779T (pt) 2020-02-21
JP2015147764A (ja) 2015-08-20
WO2015110939A1 (en) 2015-07-30
KR20160093731A (ko) 2016-08-08
MX2016009665A (es) 2016-11-14
KR20210008177A (ko) 2021-01-20
PL3096779T3 (pl) 2020-05-18
AU2015208819A1 (en) 2016-06-30
IL246637A0 (en) 2016-08-31
CA2937418A1 (en) 2015-07-30
RU2016126423A3 (https=) 2018-03-01
US20190231856A1 (en) 2019-08-01
DK3096779T3 (da) 2020-02-24
JP6624787B2 (ja) 2019-12-25
ES2772802T3 (es) 2020-07-08
HUE047588T2 (hu) 2020-04-28
AU2015208819B2 (en) 2020-01-23
US20160375109A1 (en) 2016-12-29
CN112156176A (zh) 2021-01-01
MX375355B (es) 2025-03-04
KR20180014221A (ko) 2018-02-07
CN105934250A (zh) 2016-09-07
BR112016014617A2 (pt) 2017-09-19
RU2016126423A (ru) 2018-03-01
HUE047588T4 (hu) 2020-06-29

Similar Documents

Publication Publication Date Title
GB2535253B (en) Compositions and methods
SG10202109655VA (en) Compositions and methods for immunooncology
IL251721A0 (en) Preparations and methods for the treatment of diseases of the central nervous system
PT3490582T (pt) Composições para utilização no tratamento da mielofibrose
PL3206493T3 (pl) Kompozycje i sposoby leczenia zaburzeń OUN
AP2017009674A0 (en) Methods and compositions for treating ulcers
ME03749B (me) KOMPOZICIJE I POSTUPCIZA LEČENJE POREMEĆAJA CNS-a
IL251759A0 (en) Preparations and methods for treating insomnia
PT3200815T (pt) Métodos e composições para o tratamento de cancro
IL250715A0 (en) Preparations and methods for the treatment of cultural disorders
PT3189074T (pt) Composições e métodos para tratar e prevenir a inflamação
IL246879B (en) Preparations of Epilimod and methods of using them
IL254963A0 (en) Preparations and methods for the treatment of autism
ZA201703771B (en) Compositions and methods for treating hyperkalemia
ZA201606673B (en) Compositions and methods for treating neurodegenerative diseases
HUE060394T2 (hu) Készítmények és módszerek az endometriózis kezelésére
IL253220A0 (en) Preparations and methods for the treatment of glaucoma
ZA201605109B (en) Compositions and methods for treating neutropenia
IL246637A0 (en) Preparations and methods for the treatment of intracerebral hemorrhage
IL252707B (en) Compositions and methods for treating diseases
GB201402915D0 (en) Compositions and methods
GB201521083D0 (en) Compositions for treatment and methods thereof
GB201407949D0 (en) Compositions and methods for treating biofilms
GB201421947D0 (en) Elecroplating method and composition
GB201403212D0 (en) Compositions and methods